| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 01/21/1998 | EP0660821B1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
| 01/21/1998 | EP0650363B1 Antiviral combinations |
| 01/21/1998 | EP0625977B1 Piperazine derivatives as 5-ht1a antagonists |
| 01/21/1998 | EP0594636B1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1998 | EP0536208B1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 01/21/1998 | EP0527917B1 Use of adenosine and adenosine derivatives for anesthesia |
| 01/21/1998 | CN1171115A 14 alpha, 17 alpha-C2-bridged 19-nor-progesterone derivatives |
| 01/21/1998 | CN1171114A Androstane and preg nane series for allosteric modulation of gamma-amino-butyric acid receptor |
| 01/21/1998 | CN1171112A Amino acid nucleic acids |
| 01/21/1998 | CN1171111A Diclavulanate salt of diamino ether and its preparing method |
| 01/21/1998 | CN1171110A Production of cefotaxime and new sodium salts |
| 01/21/1998 | CN1171109A Novel quinuclidine derivatives and medicinal composition thereof |
| 01/21/1998 | CN1171108A 8-alkoxyquinolonecarboxylic acid with excellent stability and process for producing the same |
| 01/21/1998 | CN1171107A Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibotors and non-steroidal anti-inflammatory products |
| 01/21/1998 | CN1171105A Use of dioxomorpholines to combat endopharasites, novel dioxomorpholines and process for their production |
| 01/21/1998 | CN1171104A Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 01/21/1998 | CN1171100A High purity N-(4-£N,N-bis(2-iodoethyl) amino|-phenoscycarbonyl|-L-glutamic acid |
| 01/21/1998 | CN1171054A Compound |
| 01/21/1998 | CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
| 01/21/1998 | CN1171050A 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same and use for treating insulin resistance |
| 01/21/1998 | CN1171047A Proliposome powder for inhalation |
| 01/21/1998 | CN1171045A Hemorrhoidal compositions and method of use |
| 01/21/1998 | CN1170761A Process for production of lipstatin and tetrahydrolipstatin |
| 01/21/1998 | CN1170722A New coumarin derivatives, processes for preparation thereof and their use |
| 01/21/1998 | CN1170719A Estrogenic agents |
| 01/21/1998 | CN1170716A Di-ortho substituted benzoyl guanidine, its preparing method, use and medicine containing them |
| 01/21/1998 | CN1170606A Compositions having inhibitive activity against 5 alpha-reductase and antibacterial activity against propionibacterium acnes |
| 01/21/1998 | CN1170602A Liniment for curing vitiligo and its preparing method |
| 01/21/1998 | CN1170590A Medicine for curing crawl disease of bee |
| 01/21/1998 | CN1170576A Basin bath medicinal liquid for curing tinea pedis, sweaty feet and smelly feet |
| 01/21/1998 | CN1170575A Treatment and prophylaxis of pancreatitis |
| 01/21/1998 | CN1170574A Sulfonamides and their use |
| 01/21/1998 | CN1170516A Growth promotion feed for chickens and method |
| 01/21/1998 | CN1037101C 4-substituted 1, 2, 4-triazole derivatives, its preparing method and use thereof |
| 01/21/1998 | CN1037063C Preparation method for antibacterial composition of oral administration |
| 01/20/1998 | US5710304 GABA and L-glutamic acid analogs for antiseizure treatment |
| 01/20/1998 | US5710294 Treatment of malignant and other diseases characterized by proliferative growth of undifferentiated cells |
| 01/20/1998 | US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
| 01/20/1998 | US5710274 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
| 01/20/1998 | US5710272 Increasing cerebral blood flow |
| 01/20/1998 | US5710259 Treating congestive heart failure |
| 01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
| 01/20/1998 | US5710246 Coupling oligopeptides; deprotecting |
| 01/20/1998 | US5710182 Topical solution of active agent, hydrophilic polymer, salt, wetting agent, preservative, water |
| 01/20/1998 | US5710181 Administering aminoguanidine |
| 01/20/1998 | US5710179 Antitumor agent |
| 01/20/1998 | US5710178 Aryl- and aryloxyalkanoic acids |
| 01/20/1998 | US5710177 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair & nails |
| 01/20/1998 | US5710176 Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/20/1998 | US5710175 Optionally acylated 1-alkenyl monoglyceride |
| 01/20/1998 | US5710174 Anticoagulants for blood disorders |
| 01/20/1998 | US5710172 Histidine as a protective agent in cardiac surgery and myocardial ischemic syndromes |
| 01/20/1998 | US5710171 Anticancer and antitumor agents |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases |
| 01/20/1998 | US5710165 Administering eliprodil |
| 01/20/1998 | US5710164 Diheterocyclic styryl nitriles |
| 01/20/1998 | US5710163 Benzo f!quinolinones |
| 01/20/1998 | US5710162 Antitumor agents |
| 01/20/1998 | US5710158 Inhibitors of protein tyrosine kinase and epidermal growth factor |
| 01/20/1998 | US5710156 Ester and carbamate derivatives of azolones |
| 01/20/1998 | US5710154 Tetrahydrofuran antifungals |
| 01/20/1998 | US5710151 Method of treating urinary bladder dysfunctions |
| 01/20/1998 | US5710150 Arginine vasopressin antagonists |
| 01/20/1998 | US5710149 Piperazine derivatives as 5-ht antagonists |
| 01/20/1998 | US5710148 Fumagillol derivatives |
| 01/20/1998 | US5710147 7-benzyloxyimino-cephalosporins |
| 01/20/1998 | US5710146 Antibiotics for bactericides |
| 01/20/1998 | US5710145 Protein kinase C inhibitor |
| 01/20/1998 | US5710143 Anti-obesity agents |
| 01/20/1998 | US5710142 Vitamin D analogues |
| 01/20/1998 | US5710141 Panthenol, acne |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/20/1998 | US5710138 Benzo f!quinoxalinedione derivatives, their production and use in pharmaceutical agents |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5710135 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/20/1998 | US5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders |
| 01/20/1998 | US5709993 Process for anticoagulation during extracorporeal blood circulation sequentially using citrate or nafamostat and heparin |
| 01/20/1998 | US5709991 Proralen inactivation of microorganisms and psoralen removal |
| 01/20/1998 | US5709888 High fat nutritional formula for infants and adults |
| 01/20/1998 | US5709884 Process for conditioning substances |
| 01/20/1998 | US5709883 Solubilized in polymer matrix blend; sustained release |
| 01/20/1998 | US5709882 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as a process for the preparation thereof |
| 01/20/1998 | US5709881 Tablet capsule or granule comprising desogestrel |
| 01/20/1998 | US5709875 Calcium phosphate, dextran; promotes regeneration of bone |
| 01/20/1998 | US5709869 Intradermal delivery of lidocaine |
| 01/20/1998 | US5709868 Lipoic acid in topical compositions |
| 01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709855 Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain |
| 01/20/1998 | US5709852 Ethylene oxide/propylene oxide/ethylene oxide (EO/PO/EO) triblock copolymer carrier blends |
| 01/20/1998 | US5709848 Photocleavable metal-chelating agents and compositions containing the same |
| 01/20/1998 | US5709816 Singlet oxygen quenchers and external compositions containing the same |
| 01/20/1998 | CA2066425C Apparatus for administering medicaments to mucosal tissue |
| 01/20/1998 | CA2059000C Fused-ring aryl substituted imidazoles |
| 01/20/1998 | CA2045212C Anti-virus agent |
| 01/19/1998 | CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use |